Manufacturers Life Insurance Company, The Ionis Pharmaceuticals Inc Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 286,279 shares of IONS stock, worth $9.42 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
286,279
Previous 308,947
7.34%
Holding current value
$9.42 Million
Previous $12.4 Million
19.13%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$542 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$466 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$377 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$340 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$285 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.67B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...